Cite
HARVARD Citation
Parisi, M. et al. (2022). Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. European journal of neurology. pp. 3611-3622. [Online].